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The purpose of this tutorial review is to illustrate the way to design new and powerful catalysts.
The ﬁrst possibility to get a biological catalyst for a given chemical process is to use existing
enzymes that catalyze related reactions. The second possibility is the use of immune systems that
recognize stable molecules resembling the transition structure of the target reaction. We ﬁnally
show how computational techniques are able to provide an enormous quantity of information,
providing clues to guide the development of new biological catalysts.
1. Introduction
Scientists have always been looking at Nature in order to ﬁnd
a source of inspiration to mimic the great power and eﬃciency
of its processes. One of these processes is reactions catalyzed
by enzymes, very complex molecular machines capable of
enhancing the rate constant of chemical reactions. The
purpose of this review is to illustrate the way in which
computational tools can be used to assist in the process of
designing new and powerful catalysts, taking as reference
natural enzymes. In this introduction we focus on two diﬀerent
kind of proteins that can be used as starting points to get new
biological catalysts. The ﬁrst possibility to get a biological
catalyst for a given chemical process is to use existing enzymes
that catalyze related reactions. As we discuss, enzymes present
a typical feature of living organisms which is the evolvability,
which means that they are not dead ends but their eﬃciency
can be enhanced or new catalytic activities derived from
existing enzymes. The second possibility is the use of immune
antibodies, designed to recognize stable molecules resembling
the transition structure of the target reaction. We show in this
review how these materials can be engineered to tailor new
activities using diﬀerent strategies. As discussed in the second
part of the paper, computational techniques are able to
provide an enormous quantity of information about chemical
reactions in complex media, providing then clues to guide the
development of new and more eﬃcient biological catalysts.
1.1 Enzyme evolvability
Enzymes display enormous reaction rate enhancements in
water at moderate pH values and mild pressures and tempera-
tures, which correspond to the standard physiological condi-
tions of living organisms. In fact, reactions with half times
approaching the age of the Earth are accelerated by many
orders of magnitude up to 1020, which is the exceptional case
of arginine decarboxylase. Other examples can be found in the
survival of paper documents or ancient ships for long periods
under water which can be explained by the fact that the
glycosidic bonds of cellulose are very resistant to hydrolysis
in the absence of cellulases that catalyse their hydrolysis.1
The traditional view on enzymes holds that their catalytic
activities, while optimized by evolution, also represent highly
dead ends (one gene, one function).2 However, it has been
aDepartament de Quı´mica Fı´sica i Analı´tica, Universitat Jaume I,
12071 Castello´n, Spain. E-mail: moliner@uji.es
bDepartament de Quı´mica Fı´sica, Universitat de Vale`ncia, 46100
Burjasot, Spain. E-mail: ignacio.tunon@uv.es
cDepartament de Quı´mica, Universitat Auto´noma de Barcelona, 08193
Bellaterra, Spain
Vicent Moliner
Vicent Moliner obtained his
PhD (1993) from the Univer-
sitat Jaume I, under the
supervision of Juan Andre´s.
He did postdoctoral studies
with Ian Williams (University
of Bath, 1996–1997), and
also with O. Tapia (Uppsala)
and J. Krechl (Prague). He
was appointed as Assistant
Professor at the University
Jaume I in 1994 and has
been a Lecturer in Physical
Chemistry since 1998. His
research interest is mainly
focused on theoretical studies of chemical reactivity in
enzyme catalysis.
In˜aki Tun˜o´n
In˜aki Tun˜o´n obtained his PhD
(1993) working on continuum
models from the Universidad de
Valencia, under the supervision
of Prof. Silla. He followed with
postdoctoral research in 1994 at
the Universite´ de Nancy with
Prof. Rivail. After one year he
got a postdoctoral position at the
Universidad de Valencia and has
been a Lecturer in Physical
Chemistry since 1998. His re-
search is focused on theoretical
studies of chemical reactivity in
enzymes and in solution.
2634 | Chem. Soc. Rev., 2008, 37, 2634–2643 This journal is c The Royal Society of Chemistry 2008
TUTORIAL REVIEW www.rsc.org/csr | Chemical Society Reviews
recently suggested that this paradigm, which has dominated
thinking in this ﬁeld in the past, could be too simplistic. In this
sense, despite an enzyme being generally deﬁned as a selective
catalyst capable of diﬀerentiating between diﬀerent substrates
and speeding up the rate of a particular chemical reaction,
some enzymes have been found to present promiscuous
activity, accepting alternative substrates and catalyzing
secondary reactions.2–6 This promiscuity provides a raw start-
ing point for the evolution of enzymes, as a new duplicated
gene presenting low activity would be the germen for adaptive
evolution.3 In fact, new enzymatic functions can evolve over a
period of years or even months, as recently happened as a
response to new synthetic chemicals or drugs.6 According to
previous studies, promiscuous activities exhibit high plasticity
as they can be readily increased by means of one or a few
mutations, allowing reaching of the threshold value for being
improved under selective pressure.3 Instead, primary activity
presents a large robustness against mutations.6 As a conse-
quence, the active sites of these existing enzymes provide
obvious materials to engineer novel enzymes with new
catalytic functions.2
Enzyme promiscuity can be classiﬁed in three diﬀerent
categories: substrate promiscuity or ambiguity (the enzyme
accepts structurally distinct substrates but catalyzes the same
chemical reaction), catalytic promiscuity (the enzyme accepts
diﬀerent substrates and catalyzes diﬀerent overall reactions),
and product promiscuity (the enzyme accepts a single sub-
strate and uses similar chemical mechanisms to catalyze the
formation of diﬀerent products).2
An example of the substrate promiscuity can be illustrated
with the cytochrome P450 (CYP), a vast superfamily of
enzymes found in almost all life forms. One of the most
striking characteristics of some CYPs is that individual
enzymes can interact with numerous structurally diverse sub-
strates. This broad speciﬁcity usually serves by its obvious
beneﬁts playing an important role in metabolism. In fact, it is
thought that more than 90% of drug and chemical oxidations
in human beings are mediated by these promiscuous enzymes,
probably based on the fact that they are not restricted to a
particular substrate.7 In general, these microsomal enzymes
determine the bioavailability of drug molecules by converting
them to more soluble, often inactive products that are readily
excreted. Another example of substrate promiscuity is the
existence of antibiotic resistance mainly due to a family of
enzymes called b-lactamases. The ancestral substrate of this
enzyme was the penicillins but, after new generations of
antibiotics were introduced, these enzymes have co-evolved,
broadening their activity to even more elaborate antibiotics.
b-Lactamases hydrolyze the b-lactam ring of antibiotics and
thereby allow survival of pathogenic bacteria challenged by
treatment with these agents. Metallo-b-lactamases, which
contain one or two zinc ions bound in the active site, have
become a severe clinical problem due to their especially broad
substrate spectra and potential for horizontal transfer.8,9
The catalytic promiscuity, the ability of an enzyme to
catalyze, at low level, a reaction other than its cognate reaction
that is maintained via selective pressure, provides a unique
opportunity to dissect the origin of enzymatic rate enhance-
ment via a comparative approach. The alkaline phosphatase
(AP) superfamily is an ideal system to be used in making such
comparison. There are enzymes belonging to this AP
superfamily, also called AP, that catalyze the hydrolysis of
phosphate monoesters but also present promiscuous activities
towards sulfate monoesters, phosphate diesters and phosphite.
Starting from this promiscuity activity, few mutations would
be needed to reach a threshold value that could provide a
selective advantage, allowing selection to optimize new
enzymes in the superfamily. These observations explain the
enzyme activity divergence of superfamilies from a common
ancestor. This could be the case with nucleotide pyro-
phosphatase/phosphodiesterase (NPP) that presents highly
common structural features with AP but preferentially hydro-
lyzes phosphate diesters.10 Another example of catalytic
promiscuity is illustrated by an enzyme that belongs to a
new group of lactonases: phosphotriesterase (PTE) which
appeared on this planet only several decades ago from a
pre-existing hydrolase. This system provides a powerful
demonstration of the evolvability of enzymes since it has
evolved for the purpose of degradation of synthetic insecti-
cides introduced in the 20th century. Although toxic to
humans, bacteria have developed ways of degrading these
compounds so that they do not accumulate in the environ-
ment. Interestingly, no naturally occurring substrate has been
identiﬁed for PTE.5,6,11
An excellent model to illustrate the last case of promiscuity,
product promiscuity, is g-humulene synthase, a sesquiterpene
synthase that is known to produce 52 diﬀerent sesquiterpenes
from a sole substrate, farnesyl diphosphate, through a wide
variety of cyclization mechanisms. The product distribution
can be very sensitive to changes in speciﬁc amino acid residues.
Nevertheless, it is extremely diﬃcult to predict the relationship
between primary amino acid sequence and product distribu-
tion. In fact, closely related enzymes within or near species
present functional disparity.12
All these previous examples of promiscuity illustrate the
enzyme evolvability; this is, their ability to adapt to new
functions. It is important to point out that improving an
enzyme does not necessary mean increasing the rate constant
of the catalytic process, instead it can be more interesting to
improve the robustness of the protein structure against a wider
range of temperatures and solvents. This target could be useful
for certain industrial purposes. The practical procedure to
modify an existing enzyme is the ﬁeld of protein engineering,
summarized in the next section.
1.2 Protein engineering
One day, we shall be able to a priori design amino acid
sequences that will fold into proteins with desired functions.
As this is not yet possible, scientists have used directed
evolution to generate molecules with novel properties starting
from natural enzymes.13 Evolution, normally applied to
animals and plants, requires the generation of variants and
diﬀerential propagation of those with favourable features.
Biologists and chemists have recently begun to use evolu-
tionary strategies to tailor the properties of individual mole-
cules instead of whole organisms. Random mutations or
recombination can, in many cases, be done eﬃciently, leading
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in this way to molecular evolution in the laboratory. The
successful variants can be identiﬁed either by screening or by
selection. While screening requires an active search of all
variants, selection is based on the exclusive survival of
organisms containing the desired variants of the protein,
mimicking the true Darwinian evolution. This is an iterative
process that requires, before starting new iterations of the
process, the favourable variants to be ampliﬁed by cloning.
The challenge is to collapse the time scale for evolution from
millions of years to months or even weeks. Evolution does not
work towards any particular direction, nor is there a goal; the
underlying processes occur spontaneously during reproduc-
tion and survival. In contrast, the laboratory evolution experi-
ments often have a deﬁned goal, and the key processes
(mutation, recombination, and screening or selection) are
carefully controlled by the experimentalist. The general
techniques of directed evolution mimic natural evolution
processes such as random mutagenesis and sexual recombina-
tion. Thus, new proteins with new desired functions can be
derived through mutations of a few residues or recombining
fragments swapped between two parent sequences.14 In this
last technique it is possible to explore distant regions of
sequence space, while this is not generally possible using
random mutations. In both cases these techniques permit us
to engineer enzymes without needing to understand them in
great detail.
Another option is the rational design approach that consists
of direct mutation of residues on selected speciﬁc positions of
proteins.15 The selection of residues to be mutated is often
deduced from X-ray diﬀraction structures of the protein–
substrate complex. Moreover, information on the molecular
mechanism of the chemical reaction is required. Mutation of a
few amino acids can render an important change in the active
site of the enzyme, while the structure of the full protein
remains almost invariant. As a consequence, signiﬁcant cata-
lytic eﬀects can be derived. However, the lack of knowledge on
the relationship between amino acid sequence, structure and
function, together with the extreme sensitivity of catalytic
activity to seemingly modest structural perturbations, make
redesign of an enzyme in the laboratory so diﬃcult. As we will
show in detail below, computational study of the catalytic
function of the protein can provide the information needed to
design successful mutations directed to a particular purpose.
It is interesting to note that while rational design is usually
focused on genetic selection that produces protein mutations
close to the active site, directed evolution techniques produce
random mutations that, most of the time, belong to regions of
the protein far from the active site. So, both strategies can be
satisfactorily combined to get an improved function.
1.3 Catalytic antibodies
Redesign of biological catalysts is not restricted to enzymes. In
particular, almost three decades ago, immune-globulin pro-
teins were used to produce catalytic antibodies (CA).16 The
immune system of living organisms can recognize and produce
antibodies to a wide range of antigens. This enormous
diversity arises from the ingenious reshuﬄing of the DNA
sequences encoding components of the antibodies. Once a
germline is selected from the pool based on its initial aﬃnity
for the antigen (also known as the hapten), additional struc-
tural diversity is generated by an aﬃnity maturation process
that can take some weeks. In this process, somatic mutations
are introduced through changes in the CA protein amino acid
sequence. This process leads to a high aﬃnity monoclonal
antibody. The most abundant of these antibodies, the immuno-
globulin proteins, consist of two identical light chains and two
identical heavy chains connected by disulﬁde bridges. Both the
light and heavy chains have a constant domain and a variable
domain, being the antigen recognizing site composed of
the variable region of both chains.
In order to understand how an antibody can be used as a
catalyst, the fundamentals of enzyme catalysis have to be
remembered. The decrease in the activation barrier in an
enzymatic process arises from the relatively larger binding
energy of the transition state (TS) when compared to the
reactants (Michaelis complex, MC). This idea can be translated
to antibodies utilising the immune response to a stable molecule
that mimics as closely as possible the presumed structural and
electronic features of the TS of a particular reaction. This is the
so called transition state analogue (TSA). Therefore the TSA
used as the hapten is a stable molecule which resembles the TS.
Just as a human hand can adapt to a large number of shapes, an
antibody active site can change its conformation to complement
diﬀerent ligands.16 Due to its intrinsic variability, a signiﬁcant
reorganization of the germline active site can occur upon ligand
binding. Afterwards, in the maturation process of a monoclonal
antibody, the optimal active site conformation is ﬁxed, increa-
sing the aﬃnity for a particular antigen. The result should be
the evolution of the antibody binding site with maximum
complementarity to the TSA and, hopefully, to the real TS.
Following these strategies, CA have been produced for a
plethora of chemical reactions, ranging from hydrolytic
reactions, sigmatropic or cycloaddition rearrangements,
carbon–carbon bond-forming reactions, redox reactions,
etc. . . An unanticipated feature of some CA is their promis-
cuity. In particular, aldolase CA can catalyze over 100 diﬀer-
ent reactions, including aldehyde–aldehyde, ketone–aldehyde,
and ketone–ketone condensations.17 Another example is the
CA 21D8, which was developed to accelerate a decarboxyl-
ation reaction, and has shown hydrolytic activity.18 These
observations suggest that certain antibody scaﬀolds are
intrinsically predisposed towards catalysis, a property that
can be enhanced and reﬁned during the aﬃnity maturation
process in response to a TSA.18 However, as a general feature,
the catalytic power of CA is never as high as the one obtained
in enzymes (106 in CA against 1020 in enzymes). Their modest
eﬃciencies appear to be a direct consequence of the simple
strategy used to generate them. Whereas the process of natural
selection optimized enzymes on the basis of their catalytic
activity, the microevolutionary mechanism of the immune
systems selects antibodies for increased aﬃnity to an
‘‘imperfect’’ TS. Although nature uses a wide variety of
diﬀerent protein scaﬀold to build enzyme active sites, there
is a limited structural diversity inherent to the immune system.
It is therefore conceivable that antibody structure itself places
intrinsic limitations on the kind of reactions amenable to
catalysis and on attainable eﬃciencies.17,18
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Diﬀerent strategies have been proposed to improve the
catalytic eﬃciency of CAs. One is based on the search for a
better hapten (TSA), as the TSA is never suﬃciently similar to
the TS. Moreover, it is diﬃcult to ﬁnd a proper TSA if the
catalyzed reaction takes place through several steps. The other
is the use of molecular engineering (based on site-directed
mutagenesis). Keeping in mind that the starting point for
rational design of CAs is frequently the X-ray structure of a
complex between the protein and a stable molecule, both
strategies present two serious drawbacks. First, the speciﬁc
pattern of interactions established between the substrate, in its
TS, and the residues of the active site does not exactly match
to the one found in the protein–substrate crystal structure
(whatever molecule was used as a substrate); and second, the
static picture obtained from X-ray crystallography techniques
does not reﬂect the ﬂexibility and dynamics of the protein. The
molecular engineering employed to improve the catalytic
eﬃciency of CAs are thus similar to the ones applied to the
redesign of enzymes. Computational design can be crucial to
improve both kinds of biological catalysts.
2. Computational design
The methods and techniques of computational chemistry have
become a promising complementary tool for the rational design
of protein structures with catalytic activity. These methods
could be classiﬁed into two classes; structure-based methods
and reaction analysis-based methods. From a methodological
point of view, the ﬁrst class are based on the application of
molecular mechanics force ﬁelds to structures deduced from
X-ray crystallographic data or from quantum mechanical
calculations on reduced active site models, while the second
group of methods use hybrid quantum mechanics/molecular
mechanics (QM/MM) techniques19 that allow to follow the
complete chemical reaction including the dynamics of the full
system. These two types of methods are described in the next
two sub-sections.
2.1 Structure-based methods
As mentioned before, it is not straightforward to deduce the
three dimensional structure of a protein from the knowledge of
its sequence of amino acids. In fact, this goal has only been
reached in proteins with a small number of residues. An
alternative strategy in protein design is to solve the problem
in the inverse way; to compute an amino acid sequence
that would fold into a target backbone structure.20 These
algorithms are based on searching for the global minimum
energy conformation of the protein in its holoform within the
frozen position of atoms belonging to the backbone. This
search is carried out in the sequence space using a library of
rotamers, which is usually based on molecular mechanics
(MM) classical force ﬁelds.
It would be even more diﬃcult to relate the structure of the
protein with its function. Optimizing the enzymatic function is
a much more subtle problem, since mutations of residues in
the active site that presumably could improve the eﬃciency of
the enzyme can decrease the stability of the full protein.
Enzymes have evolved under selective pressure to both main-
tain the stability of the overall structure and the biochemical
function. There are two opposing trends, on one hand enzymes
fold into compact structures, on the other hand they must also
be active to catalyze chemical reactions. The active site of an
enzyme is highly strained because is designed to develop
favourable interactions with the TS of the catalyzed reactions.
This strain diminishes the stability of the global structure of
the enzyme and thus a trade-oﬀ between stability and function
is established.9,21–23 Warshel suggested that charged groups
and dipoles of the active site are preorganized to preferentially
interact with the TS and, consequently, the active site of an
enzyme itself is highly strained because of unfavourable
interactions amongst these groups.24
According to the most accepted interpretation of enzyme
catalysis, optimization of catalytic function would imply the
stabilization of the TS of the catalyzed reaction by interactions
with those residues of the active site.25,26 Following these
ideas, some successful approaches to computational enzyme
design have been focused on the optimization of catalytic side-
chain contacts with small molecules placed in active sites.27 In
this sense, combinatorial optimization algorithms that inte-
grate ligand docking and placement of amino side-chain
rotamer libraries have been used to identify sequences that
form complementary ligand-binding surfaces. Obviously,
these small molecules should resemble the true TS of the
reaction in some electronic and geometrical features. This
can be accomplished using high energy reaction intermediates
as, for example, in the hydrolysis of p-nitrophenyl acetate
using a catalytically inert protein scaﬀold.28 A slightly diﬀer-
ent approach would imply the use of the TS of the reaction
optimized in the gas phase instead of high energy pseudo-
stable intermediates. This strategy has been used in the design
of variants of Escherichia coli chorismate mutase (EcCM) in
order to improve the catalytic eﬀect of the wild type en-
zyme.29,30 In this study, the target was to improve the catalytic
activity of an existing enzyme: EcCM that catalyzes the
Claisen rearrangement of chorismate to prephenate (see
Fig. 1). A gas phase optimized TS structure was docked at
the position of a TSA in the EcCM crystal structure. Then,
amino acid identities and conformations were optimized for 18
active-site residues in the presence of this ab initio calculated
TS structure. The calculations returned wild-type residues in
Fig. 1 Claisen rearrangement of chorismate to prephenate showing the conformation pre-equilibrium of the former.
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12 of the 18 designed positions, and the six mutations
predicted by the calculations were to amino acids that did
not make hydrogen bond contacts to the reacting molecule.
The variants were tested experimentally and three active site
mutants exhibited catalytic activity similar to or greater
than wild-type enzyme. One of them, the mutant Ala32Ser,
showed increased catalytic properties: larger kcat and also
larger kcat/KM.
Recently, a new strategy has been proposed that is based on
several steps starting from modelling the gas phase TS of the
chemical reaction using ab initio methods. Once structural and
electronic features of the gas phase TS are known, additional
functional groups are included in an enlarged model in an
attempt to stabilize the TS. This truncated active site is after-
wards grafted into an existing protein and then the amino acid
sequence of the protein is altered to accommodate the
changes.31,32 Thus, Ro¨thlisberger et al. have developed new
enzyme catalysts for the Kemp elimination reaction for which
no natural enzyme is known.31 This reaction takes place
through the deprotonation of a carbon atom by a general
base, as shown in Fig. 2. Stabilization of the TS of this
reaction was obtained by placing an adequate base close to
the position of the proton donor carbon atom, placing a
proton donor stabilizing the charged developed on the oxygen
atom and also stacking groups favouring the electronic
delocalization observed in the TS. In particular, these authors
used a carboxylate group (glutamate or aspartate) or a cata-
lytic dyad (histidine-aspartate) as feasible bases for the depro-
tonation reaction. The authors searched for protein backbones
capable of supporting these active site models using a large set
of protein scaﬀolds. For each candidate, MM was used to
optimize the orientation of a rigid TS and the surrounding
residues satisfying the geometrical constrains derived from the
gas phase model. Afterwards, residues were redesigned to
maximize interaction of the TS and the stability of the active
site conformation. The authors obtained high-resolution
X-ray diﬀraction structures of the designed proteins, showing
that the model and the crystal structure were virtually super-
imposable, thus validating the accuracy of the computational
method. Nevertheless, subtle deviations observed in the back-
bone indicated loop regions in which explicitly modelling
backbone ﬂexibility may yield improved designs. Obviously,
limitations due to the use of a frozen protein backbone during
the theoretical modelling, necessarily reducing the capability
of the full protein scaﬀold that can hold, ﬁx, or orient the
catalytic residues in the active site, are responsible for these
deﬁciencies. Anyway, Ro¨thlisberger et al. show that several of
their new designed enzymes revealed a promising catalytic
activity with a maximum rate enhancement of about 105.
Afterwards, directed evolution carried out in the laboratory
allowed them to arrive up to 106.
A similar strategy has been used to design artiﬁcial enzymes
with retro-aldol activity by Jiang et al.32 In this case, the design
is complicated due to the fact that this reaction takes place in
several chemical steps and thus through diﬀerent transition
states that must be stabilized. A maximum rate enhancement
of about 104 was ﬁnally reached.
It is important to point out that the performances of the
artiﬁcial enzymes obtained by Ro¨thlisberger et al.31 and by
Jiang et al.32 are quite modest compared with reaction rate
enhancements achieved by natural enzymes. In fact, the
chosen reactions, Kemp elimination and the retro-aldol
reaction, respectively, are accelerated by several catalysts,
including various synthetic compounds, catalytic antibodies,
serum albumin or various peptides. Moreover, the metho-
dology used in both studies presents the limitation that the
designed enzymes have been designed trying to optimize only
the chemical reaction steps, and not binding of substrates,
product release, pH or thermal stability. Furthermore, from a
computational point of view, there are some drawbacks in
these methodologies: ﬁrst, the TS of the catalyzed chemical
reaction step has been obtained in the gas phase, not including
the key residues of the active site, neither the rest of the protein
environment; and second, the structure of the backbone of the
protein remains frozen during the functional design modelling,
not introducing its inherent ﬂexibility and dynamics. The
introduction of backbone ﬂexibility and dynamics into func-
tional design calculations is likely to be necessary to take into
account the reorganization energy eﬀects and thus improving
activity.26 All in all, the results of Ro¨thlisberger et al.31 and
those by Jiang et al.32 have to be considered a milestone in
biochemistry as, for the ﬁrst time, artiﬁcial enzymes have been
designed for non-biological reactions.
2.2 Reaction analysis-based methods
An alternative computational protocol that, although contain-
ing some limitations, sorts out the diﬃculties present in
previous strategies is based on the analysis of the dynamics
of the chemical reaction in the protein active site. In this
method, using a hybrid QM/MM scheme, the TS of the
chemical reaction is obtained under the protein environment
eﬀect.25 In order to carry out this kind of study, a small part of
the system is described by quantum mechanics (QM), while the
rest of the system is treated by classical force ﬁelds (MM).
Then, the free energy proﬁle of the transformation from
reactants to products can be obtained as a potential of mean
force (PMF) from biased molecular dynamics simulations
using an adequate reaction coordinate. The maximum of this
proﬁle renders the TS of the reaction while the free energy
diﬀerence between this maximum and the reactants will be
related to the chemical rate constant, which can be compared
with experimental data.25
In order to design an eﬃcient and selective biological
catalyst, this methodology can be applied ﬁrst to an existing
enzyme catalyzing the same or a similar reaction, with the aim
of obtaining information on the key aspects that provide the
clues to the catalysis. In particular, the reaction analysis-basedFig. 2 Schematic representation of the Kemp elimination process.
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method allows detection of all the speciﬁc substrate–protein
interactions that are established in the active site of a catalyst,
both at the reactant complex (the Michaelis complex) and at
the TS. It is very important to point out that this pattern of
interactions is not necessary equal to the ones that can be
deduced from static X-ray diﬀraction studies of stable
TSA–protein complexes, nor are they necessarily constant
along all the stages of the reaction. A deep insight into the
evolution of the substrate–protein interactions along the
chemical reaction proﬁle can be used to deduce which residues
of the active site are responsible for the preferential stabiliza-
tion of the TS with respect to reactants. Information deduced
from this analysis can be used to design a new catalyst capable
of enhancing the rate constant of the chemical step.33,34 Thus,
one could think in a de novo design of a new biological catalyst
or to select a proper protein scaﬀold as starting point. This
latter alternative would be even less complex if an existing
enzyme catalyzes this or a similar reaction, as one could try to
mutate single residues in the active site searching for similar
eﬀects to the ones observed in this native enzyme. An adequate
protein structure to be used can be a CA, which was synthe-
sized against a TSA that resembled, as close as possible, the
real TS of the reaction to catalyze, or a native enzyme that
presented certain secondary activity catalysing the chemical
reaction that is the subject of study. It is important to point
out that, once the methodology was polished and properly
optimized, the design of eﬃcient biological catalysts would be
particularly interesting in those reactions where no native
eﬃcient enzyme was known.
An application of this strategy is illustrated with the
chorismate to prephenate rearrangement that is catalyzed by
chorismate mutase (CM) native enzymes, by a synthetic CA
(1F7), and also by a promiscuous enzyme, the isochorismate
pyruvate lyase (IPL) from Pseudomonas aeruginosa, an enzyme
that evolved over millions of years to catalyze isochorismate
transformation into pyruvate and salicylate but also presents
secondary activity catalyzing the transformation of chorismate
into prephenate. Thus, the chorismate to prephenate rearrange-
ment is an excellent candidate to show how to design a
biological catalyst by a rational design that implies directed
mutation on particular residues of the active site guided by the
catalytic features observed in native CM enzymes.
Let us ﬁrst analyze the reaction in native enzymes. As
depicted in Fig. 1, a conformational equilibrium between
reactive and non-reactive conformers precedes the conversion
of chorismate to prephenate. We call reactive reactants those
chorismate conformers closer to the TS conformation: they
present a pseudo-diaxial character (regarding the relative
orientation of the ring substituents) and a signiﬁcant closer
distance between the two carbon atoms to be bonded in the
rearrangement (C1–C9). The non-reactive reactants present a
pseudo-equatorial conformation with a longer C1–C9
distance, far from the TS. It is obvious that in gas phase the
pseudo-diequatorial chorismate conformer is the most stable
due to the presence of an intramolecular hydrogen bond. In
solution, the formation of solute–solvent hydrogen bond
interactions can dramatically change this behaviour. The
pioneering QM/MM work of Richards et al. on Bacillus
subtilis chorismate mutase (BsCM)35 demonstrated that the
inclusion of the enzyme environment in the calculations
facilitates the stabilisation of a minimum energy structure
presenting a distorted geometry compared to the ground
state structure of chorismate in gas phase: the chorismate–
enzyme complex is displaced towards the structure of the TS. In
this way, these results provided an example of the geometrical
changes induced in the substrate by the enzyme. PMF proﬁles
can be obtained for the diequatorial–diaxial and for the
short–long C1–C9 distance equilibria, in aqueous and protein
environments demonstrating also the role of the enzyme in
increasing the population of reactive reactant conformers.25
Then, using the antisymmetric combination of the forming
(C1–C9) and breaking (C3–O7) bond distances as a distin-
guished reaction coordinate, the PMF proﬁles for the chemical
step of the reaction can be obtained in aqueous solution and in
the enzyme. The resulting PMF proﬁles obtained in the CMs
(EcCM and BsCM, respectively) together with the result
obtained in water are depicted in Fig. 3a. According to these
proﬁles both enzymes are able to diminish the activation free
energy of the chemical reaction by about 8–9 kcal mol1,
Fig. 3 AM1/MM free energy proﬁles (in terms of PMFs) for the
chorismate to prephenate rearrangement obtained in diﬀerent
environments: (a) EcCM (red line), BsCM (green line), aqueous
solution (dark blue line), 1F7 (purple line) and mutated 1F7-N33S
(light blue line) CAs; (b) EcCM (red line), BsCM (green line), aqueous
solution (dark blue line), IPL (purple line) and mutated IPL A38I
(light blue line). The reaction coordinate is, in all cases, the anti-
symmetric combination of the inter-atomic distances of the breaking
and forming bonds, C3  O7 and C1  C9, respectively. Proﬁles of
Fig. 3a are obtained from the data of ref. 33, 34 and 36, while Fig. 3b is
adapted in part with permission from ref. 34, Copyright 2008 ACS.
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a result that is in very good agreement with the experi-
mental data.
Once obtained, these promising results, the substrate–
protein averaged interactions, have to be analyzed for the
TS, reactive reactants and non-reactive reactants. This analy-
sis is of particular importance as far as charge distribution of
the substrate, and as a consequence the pattern of electrostatic
interactions with protein amino acids is not necessarily con-
stant along the reaction progress. The conclusions derived
from this comparative study are that while the patterns of
interactions in the TS and the reactive reactants are very
similar, this is not the case for the non-reactive reactant
complex. This implies that while the enzyme structure remains
essentially unaltered during the reaction progress, it must be
considerably deformed to accommodate reactant conforma-
tions very diﬀerent from the TS structure. As the enzyme
deformation has an associated energy penalty, this suggests
that an enzyme site prepared to accommodate the TS should
also favour those reactants more similar to the TS structure.25
Thus, substrate geometry deformation and TS stabilization
are in fact closely related concepts having a common origin in
the enzyme structure. Moreover, from the conﬁgurations
obtained in the QM/MM MD simulation one can determine
which interactions favour the stabilization of the TS relative to
the reactant state, contributing thus to a diminution of the
activation free energy. In both enzymes, BsCM and EcCM, the
TS stabilizing interactions take place through the positively
charged residues with the two negatively charged carboxylate
groups of the substrate and the negative charge developing in
the ether oxygen.25 In BsCM, Arg7, Arg63 and Arg116 make
stronger interactions with the carboxylate group in the TS
while Arg90 stabilizes the charge on the ether oxygen. The
same role is played in EcCM by Arg11, Arg28, Arg51 and
Lys39. As pointed out in a previous review on enzyme
catalysis,25 it seems that the favourable relative substrate–
protein interactions in the TS, with respect to reactants, are
more dramatic in the enzyme than in solution. As mentioned
above, these conclusions on the origin of enzyme catalysis in
the CMs are being applied in the next step of this protocol: to
use a CA as protein scaﬀold to develop catalysts. This CA has
to present certain activity in this reaction.
The free energy proﬁle obtained for the chorismate to
prephenate rearrangement in the 1F7 CA33 is depicted in
Fig. 3a together with previously commented upon PMF
proﬁles. The resulting proﬁle is in accordance with the
expected results: the catalytic eﬃciency of the 1F7 appearing
between the catalytic power of both enzymes and the reaction
studied in solution. The analysis of the substrate–protein
interactions established in the TS of 1F7 shows how their
magnitudes are dramatically smaller than in the natural
enzymes, except for the interaction established with ArgH95
(see Fig. 4), which presents similar values to the enzymatic
ones.33 It seems that the 1F7 does not properly interact with
the two carboxylate groups of the substrate, leaving them
partially exposed to the solvent, which can be corroborated
with the strong interactions established with the water mole-
cules accessible to the cavity, much smaller than in any of the
two CMs. This result suggests that the substrate ﬁts better in
the enzyme active sites than in the CA pocket.
As pointed out in our previous paper,33 it is important to
emphasize that the pattern of interactions obtained in the TS of
the 1F7 is not equal to the TSA–CA structure coming from the
X-ray diﬀraction study (see Fig. 4). The experimentally
obtained structure of the CA–TSA complex is appreciably
diﬀerent to the TS structures located in the CA active site.
Thus, for instance, AsnH33 presents a noticeable diﬀerent
orientation in the TS–CA than in the TSA–CA complex: while
in the latter the hydrogen atoms of the amino group interact
with the hydroxyl group of the inhibitor, in the TS–CA complex
there are esteric interactions between this residue and the
aliphatic hydrogen atoms of the substrate hindering the opti-
mum positioning of the substrate into the cavity, and thus
preventing strong interactions between the carboxylate group
and amino acid residues of the inner part of the cavity. The low
capability of the 1F7 to enhance the rate constant of the
chorismate to prephenate rearrangement can be understood
from this analysis. The strong stabilizing interactions observed
in the enzyme between both carboxylate groups and the protein
are not reproduced by the immune system process when
eliciting antibodies against a stable molecule that resembles,
but is not equal to, the TS of the desired chemical transforma-
tion. Thus, it was proposed changing the AsnH33 by a serine
Fig. 4 Snapshot of the TS of the chorismate rearrangement in 1F7 and X-ray structure of the TSA in the same active site.
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residue as schematically depicted in Fig. 5. The eﬀect of this
smaller amino acid is the generation of extra space in the cavity,
allowing the ring of the substrate to slightly rotate and its
carboxylate groups to optimize the interactions with the
available residues placed in the inner part of the catalytic
cavity. In particular, the interactions established between the
carboxylate group and residues such as AsnH35 and AsnH50
are stronger in the mutated CA than in 1F7. Simultaneously,
the interactions of the substrate with the solvent molecules are
reduced, approaching to the situation observed in the CMs. The
steric hindrance of the AsnH33 with the substrate in 1F7
prevents this movement, while in the mutated CA a combina-
tion of the smaller size of the residue and the weaker interaction
established with the substrate facilitates a more favourable
relative orientation in the CA cavity. The free energy proﬁle of
the new 1F7-N33S compared to the 1F7 and previous paths
obtained in the enzyme and aqueous environment is presented in
Fig. 3a. This mutation yields a noticeable decreasing of the free
energy barrier, by comparison with the PMF obtained in the
1F7. The corresponding activation free energy is 4.5 kcal mol1
lower than the original 1F7 CA and only 2.4 kcal mol1 above
the most eﬃcient BsCM enzyme. This diminution would imply
an increasing of the rate constant by a factor of 103 at room
temperature, compared with the 1F7 CA.33
Although the present work shows how our methodology,
combined with other experimental strategies, may be used to
generate an improved catalyst from a relatively modestly
eﬃcient CA, the limited structural diversity of the immune
system together with the relatively weak substrate–CA binding
interactions that can be reached with this protein impose
inherent limits on catalysts designed from CA scaﬀolds. Thus,
the next step in this methodology is to use a diﬀerent protein
scaﬀold as starting point: a promiscuous IPL enzyme. The free
energy proﬁle, in terms of PMF, for the chorismate to
prephenate reaction carried out in the active site of the
Pseudomonas aeruginosa IPL is shown in Fig. 3b, together
with previous proﬁles obtain in CM and aqueous solution.34
As expected, the catalytic power of the CMs is much higher
than that of IPL, which is reasonable keeping in mind that the
chorismate to prephenate rearrangement is a secondary reac-
tion for the latter enzyme. In fact, IPL provides a free energy
barrier lowering of only 2.3 kcal mol1 with respect to the
reaction in aqueous solution, while CMs are able to reach a
diminution of the free energy barrier about 4 times larger.
From the analysis of the reaction process carried out in the
active site, it can be concluded that the catalytic active site of
this IPL does not perfectly ﬁt to the chorismate substrate. In
particular we have analyzed the diaxial or diequatorial
character of the substrate located in the IPL active site along
the reaction proﬁle. The evolution of the dihedral angle
deﬁning the diaxial character of the substrate, as a function
of the reaction coordinate, obtained in the CMs, water and
IPL is presented in Fig. 6. It is observed how the pseudo-
diaxial character, required in the TS, is lost in the reactant
state obtained in IPL and in water solution, while the active
sites of EcCM and BsCM constrain the substrate avoiding a
complete relaxation of the substrate that would render a non-
reactive reactant conformation. It seems that IPL is not able to
retain this favourable conformation from TS to reactants,
undoubtedly due to the fact that the active site is not perfectly
suited to accommodate the substrate of this reaction.
In order to understand this diﬀerent behaviour of IPL with
respect to CMs, the interactions of the enol pyruvyl moiety of
the substrate in the active sites of IPL and EcCM (which is the
most closely related structure) were compared. A deeper
insight into the substrate–protein pattern of interaction in
EcCM reveals that there is a hydrophobic valine residue
(Val35) that constrains the position of the ether bridge.34
Fig. 5 Schematic representation of the substrate–protein interactions in the active site of the 1F7 and the 1F7-N33S CAs at their respective TSs
showing the eﬀect of AsnH33Ser mutation. Adapted in part with permission from ref. 33. Copyright 2007 Wiley-VCH.
Fig. 6 O7C3C4O11 dihedral angle evolution (in degrees) as a func-
tion of the reaction coordinate. EcCM (red line), BsCM (green line),
IPL (purple line), IPL-A38I (light blue line) and in aqueous solution
(dark blue line). Adapted in part with permission from ref. 34.
Copyright 2008 ACS.
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The equivalent residue in IPL is a smaller alanine (Ala38) that
cannot perform the same role. Thus, we decided to carried out
an in silicomutation of this residue to a larger one (from Ala to
Ile) and to repeat the PMF for the chorismate to prephenate
reaction.34 The result of this mutation is that the mentioned
dihedral angle evolution on the mutated IPL enzyme is closer
to the CMs than to the native IPL or water (see Fig. 6). The
active site of the engineered enzyme is better suited for the
chorismate to prephenate rearrangement than the original one.
In fact we have computed the contribution of the electrostatic
interactions to catalysis as the diﬀerence between the enzyme–
substrate interaction free energy in the TS and in the
reactant state. This contribution is 8.6 kcal mol1 in IPL
and 11.8 kcal mol1 in the mutated enzyme. This change is
reﬂected in the energetics of the chemical reaction; as shown
in Fig. 3b the free energy barrier in the mutated IPL is
4.4 kcal mol1 lower than in the native IPL, being only
2.0 kcal mol1 above the primary reaction catalyzed by
BsCM.34,36
As mentioned in the structure-based methods section, Mayo
and co-workers carried out an extensive study to improve the
catalytic activity of CMs. After performing 19 possible amino
acid substitutions applied over 6 diﬀerent positions of the
engineered chorismate mutase domain of EcCM, a Val35Ile
mutation was obtained that renders an increase in the kcat of
about 1.5 times.30 Moreover, mutation of Val to Ala (the same
residue present in IPL) reduces the kcat by a factor of 2. Thus,
the overall eﬀect for a Ala35Ile mutation in EcCM is an
increase in the kcat of a factor of 3. Obviously, the predicted
eﬀect for the same mutation in the equivalent position in IPL
(Ala38Ile) is much larger, which is consistent with the fact that
this enzyme is not specialized in the catalysis of the chorismate
to prephenate rearrangement. Our results are in agreement
with this study of Mayo et al.; by analyzing the full reaction
mechanism the method can render both a prediction about the
eﬀect of a mutation on IPL and an interpretation about the
success of a Val35Ile mutation in EcCM. According to Fig. 6 a
mutation of Val to a similar but larger amino acid at position
35 would keep the enol pyruvyl moiety in a diaxial conforma-
tion closer to the TS geometry and reducing then the free
energy barrier. In this sense, QM/MM MD simulations of the
Val35Ile variant of EcCM have been carried out, verifying that
the proposed mutation increases the diaxial character of
reactants by about 3 degrees. The experimental data of Mayo
and co-workers give credence to the theoretical predictions
obtained for IPL and allows conﬁdence in this reaction
analyzed-based method. Moreover, although the method has
been applied to a reaction that is also catalyzed by a native
enzyme, there is no need in having a reference catalyzed
reaction to obtain the key features that can provoke catalysis.
In fact, this method will be of maximum interest for those
reactions where no enzyme is known.
3. Future perspectives
In this review we have presented diﬀerent strategies that can be
used to assist the development of new biological catalysts
supported with computational chemistry techniques:
structure-based methods and reaction-analysis based methods.
The ﬁrst group of methods are mainly based on the knowledge
of the X-ray diﬀraction structure of a protein complexed with
a substrate resembling the properties of the real TS of the
chemical reaction or modelled from a rigid gas phase TS
structure. Thus, these kinds of methods are focused on the
optimization of catalytic side-chain contacts with molecular
structures placed in active sites. These molecules, which have
to resemble the true TS of the chemical reaction, are high
energy pseudo-stable intermediates or TS structures optimized
in gas phase or in reduced active site models. Then, combina-
torial optimization algorithms that integrate ligand docking
and placement of amino side-chain rotamer libraries can be
carried out in order to optimize the interactions. Thus, these
methods can be considered as a computational screening
algorithm that dramatically reduces the number of putative
mutations to be performed in the laboratory. Although
impressive results have been obtained, some inherent draw-
backs are present in these methodologies: ﬁrst, the real TS of
the catalyzed chemical reaction step is not considered and,
second, the structure of the backbone of the protein remains
frozen during the functional design modelling, not introducing
its inherent ﬂexibility and dynamics. Some progress may be
achieved in introducing the ﬂexibility of the backbone in the
simulations,37 but an upper limit will be always present; as far
as the TS of the chemical reaction, which implies breaking and
forming bonds, it cannot be described by using classical MM
force ﬁelds and without including the inﬂuence of a protein
environment able to adapt to the changes taking place during
the reaction progress. Moreover, focusing the study on just the
TS of the chemical reaction implies that reorganization energy,
which is one of the key terms of catalysis,26 is not considered in
these molecular modelling methods.
The second strategy, based on the analysis of the reaction
process in a realistic environment, can be considered as a step
forward from the previous one and tries to overcome its
limitations. The chemical reaction is studied by means of
hybrid QM/MM methods in the presence of the protein.
Afterwards, with a deep insight into the origin of the relative
stabilization of the TS, and the analysis of those residues of the
active site playing a key role in the reaction, several mutations
can be proposed and checked in silico.
The improvement in the catalytic power of experimentally
synthesized CAs or native enzymes that presented a threshold
catalytic eﬃciency in a certain chemical reaction can be
obtained after single mutations chosen by computational
protein engineering. These methods can be considered as the
benchmark, providing a powerful in silico test for guiding
improvements in computational enzyme design. Nevertheless,
it must be kept in mind that these methods are applied
exclusively to the chemical step, trying to optimize the perfor-
mance of the protein by reducing its free energy barrier, while
other steps of the full catalytic process could be aﬀected by the
single mutations performed on the active site of the protein. It
would be desirable to extend these methodologies to analyze
the inﬂuence of mutations on steps like the Michaelis complex
formation or the product release in order to improve the
substrate aﬃnity or the catalytic turnover, respectively. It
must be taken into account that the theoretical study of these
two steps presents additional diﬃculties related to the large
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protein conformational changes inherent to the reactant
complex formation and product release steps. Further im-
provements in simulation methods, focused to perform much
larger conformational searches and/or the use of higher levels
of theory in the description of the QM region of the system,
will arrive in the near future. These provisions are supported
by the dramatic increase in the computer capabilities and the
eﬃciency of new algorithms. Anyway, improved and simpli-
ﬁed theoretical protocols are desirable to reduce the time
required to predict successful mutations. In this sense, the
use of interaction energies and/or free energies seems to be a
promising tool provided the real TS of the reaction, under the
inﬂuence of a ﬂexible environment, is known. It would be also
desirable in the future for an improvement in the theoretical
protocol that would allow reducing the number of steps in the
theoretical screening and speeding up the predictions.
Another aspect that should also be incorporated in the
future is the thermal stability of the enzyme or their robustness
against pressure or pH conditions, which are obviously
aﬀected by mutations. One of the goals that could be envi-
saged in the near future is the prediction of mutations that
enhance the stability of a given biological catalyst (native or
engineered).
As a ﬁnal summary, theoretical tools are able to provide an
enormous amount of detailed knowledge that is not always
available from experimental techniques, oﬀering then alter-
native ways to analyze and understand the chemical process
under study. The theoretical strategies presented here can be
considered as a numerical experiment helping experimentalists
in active-site redesign by means of a few directed mutations.
We are sure that some eﬀorts in this direction will be presented
with impressive results in the next few years, probably com-
bining the advantages of the two main methods presented in
this review.
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